ScholarIQanswers from OpenAlex

A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency

PaperCitations, authors & open-access status

A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency have?

ScholarIQcitation count

A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency has 247 citations in the OpenAlex counts ScholarIQ stores.

When was A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency published?

ScholarIQyear

A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency has 2015 year in the ScholarIQ index.

What is the open-access status of A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency?

ScholarIQoa status

A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency has bronze oa status in the ScholarIQ index.

What is the DOI of A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency?

ScholarIQdoi

The DOI for A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency is on the source record.

What is the PMID of A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency?

ScholarIQpmid

The PMID for A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency is on the source record.

What is the OpenAlex record for A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency?

ScholarIQopenalex

The OpenAlex for A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial